Skip to main content
SpringerLink
Log in

The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Autoimmune response against myocardial antigens is evident in numerous heart diseases. Both the induction of an autoimmune response and the pathogenesis of autoimmune heart diseases are not fully understood. The humoral immune response may play an important role via induction of cardiomyocyte apoptosis, alteration of myocardial mechanical and electrophysiological functions, and activation of the complement system and cell-mediated cytotoxicity. Anti-β-1 adrenergic receptor antibodies appear to contribute to the pathogenesis of dilated cardiomyopathy, heart failure, and Chagas disease. Herein, we review the current knowledge relating to anti-β-1 adrenergic receptor antibodies: their potential role in heart diseases and the potential benefits of a targeted therapy against their apparently destructive effects. Patients with dilated cardiomyopathy with circulating stimulatory anti-β-1 adrenergic receptor autoantibodies are probably at a higher risk for adverse outcome and should be treated with adrenergic receptor antagonists, and possibly with immunotherapy. Further research is required to determine which patients will gain additional clinical benefits from anti-autoantibody-targeted therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7–14

    Article  PubMed  Google Scholar 

  2. Nussinovitch U, Shoenfeld Y (2009) Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp 57:95–104

    Article  Google Scholar 

  3. Brucato A, Maestroni S, Cumetti D et al (2008) Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 8:44–47

    Article  PubMed  CAS  Google Scholar 

  4. Gershwin ME (2008) The mosaic of autoimmunity. Autoimmun Rev 7:161–163

    Article  PubMed  Google Scholar 

  5. Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213

    Article  PubMed  Google Scholar 

  6. Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8:384–387

    Article  PubMed  CAS  Google Scholar 

  7. Zifman E, Amital H, Gilburd B, Shoenfeld Y (2008) Antioxidants and smoking in autoimmune disease—opposing sides of the seesaw? Autoimmun Rev 8:165–169

    Article  PubMed  Google Scholar 

  8. Sitia S, Atzeni F, Sarzi-Puttini P et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286

    Article  PubMed  Google Scholar 

  9. Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 7:42–45

    Article  PubMed  CAS  Google Scholar 

  10. Fritzler MJ (2008) Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7:616–620

    Article  PubMed  CAS  Google Scholar 

  11. Briani C, Samaroo D, Alaedini A (2008) Celiac disease: from gluten to autoimmunity. Autoimmun Rev 7:644–650

    Article  PubMed  CAS  Google Scholar 

  12. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234–8240

    PubMed  CAS  Google Scholar 

  13. Bizzaro N (2007) Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 6:325–333

    Article  PubMed  CAS  Google Scholar 

  14. Jahns R, Boivin V, Hein L et al (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419–1429

    PubMed  CAS  Google Scholar 

  15. Sterin-Borda L, Cossio PM, Gimeno MF et al (1976) Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects. Cardiovasc Res 10:613–622

    Article  PubMed  CAS  Google Scholar 

  16. Yoshikawa T, Baba A, Nagatomo Y (2009) Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 73:602–607

    Article  PubMed  CAS  Google Scholar 

  17. Jane-wit D, Altuntas CZ, Johnson JM et al (2007) Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 116:399–410

    Article  PubMed  CAS  Google Scholar 

  18. Nikolaev VO, Boivin V, Stork S et al (2007) A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50:423–431

    Article  PubMed  CAS  Google Scholar 

  19. Chiale PA, Ferrari I, Mahler E et al (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765–1771

    Article  PubMed  CAS  Google Scholar 

  20. Nagatomo Y, Yoshikawa T, Kohno T et al (2009) A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15:224–232

    Article  PubMed  CAS  Google Scholar 

  21. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36:1280–1287

    Article  PubMed  CAS  Google Scholar 

  22. Freedman NJ, Lefkowitz RJ (2004) Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 113:1379–1382

    PubMed  CAS  Google Scholar 

  23. Tutor AS, Penela P, Mayor F Jr (2007) Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Cardiovasc Res 76:51–60

    Article  PubMed  CAS  Google Scholar 

  24. Hebert TE (2007) Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists? Cardiovasc Res 76:5–7

    Article  PubMed  CAS  Google Scholar 

  25. Nussinovitch U, Katz U, Nussinovitch M, Blieden L, Nussinovitch N (2009) Echocardiographic abnormalities in familial dysautonomia. Pediatr Cardiol 30:1068–1074

    Article  PubMed  Google Scholar 

  26. Stork S, Boivin V, Horf R et al (2006) Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152:697–704

    Article  PubMed  Google Scholar 

  27. Christ T, Wettwer E, Dobrev D et al (2001) Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33:1515–1525

    Article  PubMed  CAS  Google Scholar 

  28. Medei EH, Nascimento JH, Pedrosa RC et al (2008) Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration. Europace 10:868–876

    Article  PubMed  Google Scholar 

  29. Nussinovitch N, Livneh A, Katz K et al (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353–1356

    Article  PubMed  Google Scholar 

  30. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 37:418–424

    Article  PubMed  CAS  Google Scholar 

  31. Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin—indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7:445–452

    Article  PubMed  Google Scholar 

  32. Staudt Y, Mobini R, Fu M, Felix SB, Kuhn JP, Staudt A (2003) Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 466:1–6

    Article  PubMed  CAS  Google Scholar 

  33. Wallukat G, Muller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806

    Article  PubMed  Google Scholar 

  34. Caforio AL, Tona F, Bottaro S et al (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41:35–45

    Article  PubMed  CAS  Google Scholar 

  35. Mobini R, Staudt A, Felix SB et al (2003) Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 20:345–350

    Article  PubMed  CAS  Google Scholar 

  36. Muller J, Wallukat G, Dandel M et al (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385–391

    Article  PubMed  CAS  Google Scholar 

  37. Gao Y, Liu HR, Zhao RR, Zhi JM (2006) Autoantibody against cardiac beta1-adrenoceptor induces apoptosis in cultured neonatal rat cardiomyocytes. Acta Biochim Biophys Sin 38:443–449

    Article  PubMed  CAS  Google Scholar 

  38. Mao W, Fukuoka S, Iwai C et al (2007) Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine. Am J Physiol Heart Circ Physiol 293:H1636–1645

    Article  PubMed  CAS  Google Scholar 

  39. Liang CS, Mao W, Liu J (2008) Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 41:434–441

    Article  PubMed  CAS  Google Scholar 

  40. Nussinovitch U, Shoenfeld Y (2010) Anti-troponin autoantibodies and the cardiovascular system. Heart 96:1518–1524

    Article  PubMed  CAS  Google Scholar 

  41. Chiale PA, Garro HA, Schmidberg J et al (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors. Heart Rhythm 3:1182–1186

    Article  PubMed  Google Scholar 

  42. Magnusson Y, Marullo S, Hoyer S et al (1990) Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86:1658–1663

    Article  PubMed  CAS  Google Scholar 

  43. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29:43–51

    Article  PubMed  Google Scholar 

  44. Jahns R, Boivin V, Siegmund C, Boege F, Lohse MJ, Inselmann G (1999) Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. J Am Coll Cardiol 34:1545–1551

    Article  PubMed  CAS  Google Scholar 

  45. Nishikubo K, Imanaka-Yoshida K, Tamaki S et al (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29:146–153

    Article  PubMed  CAS  Google Scholar 

  46. Li HS, Ligons DL, Rose NR (2008) Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7:168–173

    Article  PubMed  CAS  Google Scholar 

  47. Nussinovitch U, Shoenfeld Y (2008) Autoimmune dilated cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic criteria in autoimmune diseases. The Humana Press Inc, New Jersey, USA, pp 367–372

    Chapter  Google Scholar 

  48. Lazzerini PE, Capecchi PL, Guideri F et al (2008) Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 103:1–11

    Article  PubMed  CAS  Google Scholar 

  49. Aso S, Yazaki Y, Kasai H et al (2009) Anti-beta 1-adrenoreceptor autoantibodies and myocardial sympathetic nerve activity in chronic heart failure. Int J Cardiol 131:240–245

    Article  PubMed  Google Scholar 

  50. Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM (2006) Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas’ heart disease. Microbes Infect 8:2459–2464

    Article  PubMed  CAS  Google Scholar 

  51. Mahler E, Sepulveda P, Jeannequin O et al (2001) A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor. Eur J Immunol 31:2210–2216

    Article  PubMed  CAS  Google Scholar 

  52. Labovsky V, Smulski CR, Gomez K, Levy G, Levin MJ (2007) Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol 148:440–449

    Article  PubMed  CAS  Google Scholar 

  53. Kivity, S., Katz, U., Daniel, N., Nussinovitch, U., Papageorgiou, N., Shoenfeld, Y. (2009) Evidence for the use of intravenous immunoglobulins-a review of the literature. Clin Rev Allergy Immunol 38:201–269

    Google Scholar 

  54. Schimke I, Muller J, Dandel M et al (2005) Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. J Clin Apher 20:137–142

    Article  PubMed  Google Scholar 

  55. Staudt A, Bohm M, Knebel F et al (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106:2448–2453

    Article  PubMed  CAS  Google Scholar 

  56. Baba A, Akaishi M, Shimada M et al (2010) Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure. Circ J 74:1372–1378

    Article  PubMed  CAS  Google Scholar 

  57. Matsui S, Larsson L, Hayase M et al (2006) Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J Mol Cell Cardiol 41:78–85

    Article  PubMed  CAS  Google Scholar 

  58. Ruffatti A, Marson P, Pengo V et al (2007) Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 6:196–202

    Article  PubMed  Google Scholar 

  59. Gesinde MO, Tan LB, Gooi HC (2007) Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy. J Clin Apher 22:241–242

    Article  PubMed  CAS  Google Scholar 

  60. Miao GB, Liu JC, Liu MB et al (2006) Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment. Eur J Clin Investig 36:614–620

    Article  CAS  Google Scholar 

  61. Levin MJ, Hoebeke J (2008) Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease. Autoimmunity 41:429–433

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We wish to thank Phyllis Curchack Kornspan for her editorial assistance.

Author information

Authors and Affiliations

  1. Department of Internal Medicine B and Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel

    Udi Nussinovitch & Yehuda Shoenfeld

  2. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, Israel

    Udi Nussinovitch

  3. Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel

    Yehuda Shoenfeld

Authors
  1. Udi Nussinovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Shoenfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nussinovitch, U., Shoenfeld, Y. The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease. Clinic Rev Allerg Immunol 44, 75–83 (2013). https://doi.org/10.1007/s12016-010-8228-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-010-8228-9

Keywords

Search

Navigation